Crosspoint Capital Strategies, LLC - QIAGEN NV ownership

QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 190 filers reported holding QIAGEN NV in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Crosspoint Capital Strategies, LLC ownership history of QIAGEN NV
ValueSharesWeighting
Q2 2015$14,000
-6.7%
570
-2.9%
0.00%
-42.9%
Q1 2015$15,0005870.01%
Other shareholders
QIAGEN NV shareholders Q3 2015
NameSharesValueWeighting ↓
Exane Asset Management 642,752$14,260,214,0005.53%
Tikvah Management LLC 369,425$8,057,0004.72%
Hardman Johnston Global Advisors LLC 3,797,024$82,813,0004.22%
HealthCor Management, L.P. 2,500,000$54,525,0002.97%
Opus Point Partners Management, LLC 105,751$2,306,0002.23%
CRAMER ROSENTHAL MCGLYNN LLC 4,018,074$87,634,0001.41%
Douglas Lane & Associates, LLC 1,942,678$42,370,0001.22%
PLATINUM INVESTMENT MANAGEMENT LTD 2,167,768$47,279,0001.17%
MANNING & NAPIER ADVISORS LLC 6,111,364$133,287,0000.81%
PRIMECAP MANAGEMENT CO/CA/ 20,128,325$438,999,0000.47%
View complete list of QIAGEN NV shareholders